Nutrient quality
Substantial milk-thistle extract and choline amounts fit liver support well. Missing silymarin standardization and an undefined absorption blend limit quality confidence.
| $ 20.97 | ||
Vitacost | $ 22.99 |
Milk thistle seed extract and choline bitartrate form the central liver-support pair. Dandelion, inositol, and alfalfa add related but less clearly targeted support.
The milk thistle amount is large by weight, yet no silymarin percentage or active-marker yield is stated. An undefined BioAccelerators blend cannot be credited with improving absorption.
The three-tablet serving is less convenient than a concentrated capsule. The formula may suit users wanting a broad liver-oriented blend, but not those seeking verified high-potency silymarin.
Substantial milk-thistle extract and choline amounts fit liver support well. Missing silymarin standardization and an undefined absorption blend limit quality confidence.
Most main ingredients have specific amounts. An undefined BioAccelerators blend, missing silymarin yield, incomplete directions, and absent tablet excipients limit transparency.
The supplied satisfaction metric is strong and response volume is substantial. Specific firsthand feedback was not supplied, so recurring complaints and purpose alignment remain uncertain.
Substantial core ingredients and a reasonable serving cost provide fair value. Missing milk-thistle potency and the hidden absorption blend keep it only moderately competitive.
Milk thistle provides liver-cell protection, while choline supports healthy liver fat handling and dandelion may support bile flow. The 552 mg extract weight is substantial, but no silymarin percentage or active amount is disclosed.
Alfalfa and inositol broaden the blend without adding a clearly strong detox pathway, and the undefined BioAccelerators blend does not prove better absorption. Alfalfa can contain vitamin K, which may complicate stable dosing for people using warfarin-type anticoagulants.
| Ingredient | Amount per serving |
|---|---|
Choline (Choline Bitartrate) | 240 mg |
Milk Thistle seed extract (Silymarin) | 552 mg |
Dandelion | 324 mg |
Alfalfa leaf extract | 324 mg |
Inositol | 240 mg |
Futurebiotics BioAccelerators | 23 mg |
Choline bitartrate provides a practical systemic form for general choline and liver support, but it is not a premium brain-targeted form. The 240 mg dose is clearly disclosed and more substantial than many low-dose blends. Requiring three tablets and offering weak cost efficiency per unit of choline are the main trade-offs.
The formula uses a clearly identified milk thistle seed extract, but it does not disclose a silymarin percentage or active-marker amount. A standard dry tablet and an undefined BioAccelerators blend provide little evidence of improved silymarin absorption. The above-median serving cost is difficult to justify when potency cannot be confirmed.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.